805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment

Andrew R. Clamp, Jonathan A. Ledermann, Mahesh Parmar et al.|Annals of Oncology|2020

Cited by 4